- Editorial
668 Views
1 Page
In this Issue of Current Oncology
- M. McLean
The Editorial Board is pleased to announce that Current Oncology is now included in the U.S. National Library of Medicine’s PubMed search engine. [...]
- 3.4Impact Factor
- 4.9CiteScore
- 23 daysTime to First Decision
- Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Current Oncology, Volume 14, Issue 3
2007 June - 6 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (6)
- Article
2 Citations
777 Views
3 Pages
Canadian Institutes of Health [...]
- Article
49 Citations
1,544 Views
7 Pages
The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial
- H. Richardson,
- D. Johnston,
- J. Pater and
- P. Goss
Several large phase iii trials have demonstrated that tamoxifen—and more recently, raloxifene—can effectively reduce the incidence of invasive breast cancer by 50%. However, these selective estrogen receptor modulators can also be associated with sev...
- Article
33 Citations
1,894 Views
14 Pages
Alemtuzumab in Chronic Lymphocytic Leukemia
- G. Fraser,
- C.A. Smith,
- K. Imrie,
- R. Meyer and
- The Hematology Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
Questions: (1) With respect to outcomes such as survival, response rate, response duration, time to progression, and quality of life, is alemtuzumab a beneficial treatment option for patients with B-cell chronic lymphocytic leukemia (CLL)? (2) What t...
- Article
96 Citations
2,459 Views
8 Pages
Canadian Recommendations for the Treatment of Glioblastoma Multiforme
- W.P. Mason,
- R. Del Maestro,
- D. Eisenstat,
- P. Forsyth,
- D. Fulton,
- N. Laperrière,
- D. Macdonald,
- J. Perry,
- B. Thiessen and
- The Canadian GBM Recommendations Committee
Recommendation 1: Management of patients with glioblastoma multiforme (GBM) should be highly individualized and should take a multidisciplinary approach involving neuro-oncology, neurosurgery, radiation oncology, and pathology, to optimize treatment...
- Article
16 Citations
1,172 Views
5 Pages
In medicine, assigning priorities for original ideas and for first implementation of a new type of treatment or technology—radium afterloading, for example—is often difficult. This situation is certainly true for radium therapy, with conflicting clai...
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Curr. Oncol. - ISSN 1718-7729